Targeting Inhibition of Fibroblast Activation Protein-α and Prolyl Oligopeptidase Activities on Cells Common to Metastatic Tumor Microenvironments

• Published in: Neoplasia (New York, N.Y.) N.Y.), 2013-04, Vol.15 (4), p.348-358
• Main Authors: Christiansen, Victoria J, Jackson, Kenneth W, Lee, Kyung N, Downs, Tamyra D, McKee, Patrick A
• Format: Article
• Language: English
• Subjects: Amino Acid Sequence; Angiogenesis; Antineoplastic Agents - pharmacology; Cell Line, Tumor; Endothelial Cells - enzymology; Fibroblasts - drug effects; Fibroblasts - enzymology; Gelatinases - antagonists & inhibitors; Gelatinases - chemistry; Gelatinases - metabolism; Humans; Membrane Proteins - antagonists & inhibitors; Membrane Proteins - chemistry; Membrane Proteins - metabolism; Mesenchymal Stem Cells - enzymology; Microvessels - pathology; Molecular Sequence Data; Neoplasm Metastasis; Oligopeptides - pharmacology; Oncology; Serine Endopeptidases - chemistry; Serine Endopeptidases - metabolism; Serine Proteinase Inhibitors - pharmacology; Tumor Microenvironment
• ISSN: 1476-5586; 1522-8002; 1476-5586; 1522-8002
• DOI: 10.1593/neo.121850

Abstract Fibroblast activation protein (FAP), a membrane prolyl-specific proteinase with both dipeptidase and endopeptidase activities, is overexpressed by reactive stromal fibroblasts during epithelial-derived cancer growth. FAP digests extracellular matrix as tissue is remodeled during cancer expansion and may also promote an immunotolerant tumor microenvironment. Recent studies suggest that nonspecific FAP inhibitors suppress human cancer xenografts in mouse models. Prolyl oligopeptidase (POP), another prolyl-specific serine proteinase, is also elevated in many cancers and may have a regulatory role in angiogenesis promotion. FAP and POP cell-associated activities may be targets for diagnosis and treatment of various cancers, but their accessibilities to highly effective specific inhibitors have not been shown for cells important to cancer growth. Despite their frequent simultaneous expression in many cancers and their overlapping activities toward commonly used substrates, precise, separate measurement of FAP or POP activity has largely been ignored. To distinguish each of the two activities, we synthesized highly specific substrates and inhibitors for FAP or POP based on amino acid sequences surrounding the scissile bonds of their respective putative substrates. We found varying amounts of FAP and POP protein and activities on activated fibroblasts, mesenchymal cells, normal breast cells, and one breast cancer cell line, with some cells exhibiting more POP than FAP activity. Replicating endothelial cells (ECs) expressed POP but not FAP until tubulogenesis began. Targeting FAP-positive cells, especially mesenchymal stem cells and cancer-associated fibroblasts for inactivation or destruction, and inhibiting POP-producing EC may abrogate stromal invasion and angiogenesis simultaneously and thereby diminish cancer growth.